Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001219036-22-000004
Filing Date
2022-01-18
Accepted
2022-01-18 17:02:50
Documents
1
Period of Report
2022-01-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164254335517439.html 4  
1 FORM 4 wf-form4_164254335517439.xml 4 2565
  Complete submission text file 0001219036-22-000004.txt   3888
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
LANCHBURY JERRY S (Reporting) CIK: 0001219036 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 22535838